A three-year neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating neuropathic pain, which affects about 400,000 New Zealanders or 8 per cent of the country’s population
Cannasouth has today signed a supplier agreement with WEECO Pharma GMBH based in Germany for the supply of cannabis flower from New Zealand into Europe
“Doctors are increasingly engaged about medicinal cannabis. They’re receiving a lot more enquiries from patients and so they’re keen to learn more about prescribing it,” says Don Budge of MCinfo
Access to cannabis-based products for medical reasons is technically legal in New Zealand. But changes to the legislation in 2020 have failed to make this potentially life altering option a reality for many
“Australia is ahead when it comes to the production and uptake of medicinal cannabis, yet New Zealand’s scheme gives doctors and patients one key advantage,” says Julie Curphey, chief commercial officer at Helius Therapeutics
The first medicinal cannabis clinic to open outside of Auckland is one of a growing number of niche providers dedicated to prescribing legal cannabis products
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management